The therapeutic potential of bromocriptine in neuropsychological rehabilitation of patients with acquired brain damage.
1. Activation of neuropsychological rehabilitation by pharmacological agents is a promising therapeutic strategy. 2. Reports of single cases and case series claim improvement of akinetic mutism, non-fluent aphasia, apathy, attentional and other neuropsychiatric disturbances after treatment with bromocriptine, a D2 dopamine receptor agonist. 3. A critical review of published reports and own experiences discusses the results in the light of pharmacological and neurobiological considerations. 4. Dopaminergic stimulation after certain kinds of brain damage might influence neuronal recovery and/or substitute dopaminergical linked functions after destruction of the corresponding neurons. 5. Although controlled clinical studies are very difficult to design and such evidence is still lacking, preliminary recommendations are given with regard to differential indications, drug regime and evaluation criteria.
City Hospital München-Bogenhausen, Department of Neuropsychology, Germany.
U
U
Müller
D Y
DY
von Cramon
D001930:Brain Injuries / Q000523:psychology / Q000534:rehabilitation*; D001971:Bromocriptine / Q000627:therapeutic use*; D006801:Humans
D001971:Bromocriptine